Replies to post #3192 on RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

<<This implies they don't have definitive CX717 data to submit that will remove the cloud entirely from it. Meaning AD and not ADHD for CX717?>>

That is incorrect. They were working on CX701 as a backup before CX717 ever ran into clinical hold problems. Everyone wants a backup, either to include in a deal, or to develop inhouse for orphans. They can't be sure what the FDA is going to do or say, but that has nothing to do with wanting a backup in the clinic.They wanted and needed that no matter what.

NeuroInvestment

[Ticonderoga221]

Yes, but the 20% or so shares additional to yesterday's float devalue everyone's shares now.

Further, I do not think the ability to sell the options they received is contingent on performance.

Meanwhile, enough with the speculation. It is absolutely wrong, and I hope is or will be illegal, for Cortex to operate by withholding vital information.